期刊文献+

ER Bcl-2在宫颈病变发生中的相关性研究 被引量:2

Correlation of ER with Bcl-2 in cervical cancer and pre-cancerous lesion
下载PDF
导出
摘要 目的:探讨ER、Bcl-2蛋白在不同程度宫颈病变中的相关性及意义。方法:免疫组织化学检测慢性宫颈炎20例、低度宫颈上皮内瘤变30例、高度宫颈上皮内瘤变70例及80例宫颈癌组织中ER和Bcl-2蛋白的表达。结果:ER在慢性宫颈炎组中阳性率为75%,随着宫颈病变程度的加重,其表达率逐渐降低(χ2=24.266,P〈0.01),与慢性宫颈炎组比较,CINⅡ~Ⅲ组和宫颈鳞癌组差异有统计学意义,CINⅠ组差异无统计学意义(χ2=0.751,P=0.386)。与肿瘤组织类型及病理分级无关;BCL-2在宫颈鳞癌组中阳性率为75.38%,随着宫颈病变程度的加重,其表达率逐渐增高(χ2=27.715,P〈0.01),与慢性宫颈炎组比较,CINⅠ组、CINⅡ~Ⅲ组及宫颈鳞癌组差异均有统计学意义。与宫颈鳞癌病理分级相关(χ2=4.862,P=0.027),与肿瘤组织类型无关(P=0.500);CINⅡ~Ⅲ组中联合表达阳性率为38.57%(27/70),宫颈鳞癌组中联合表达阳性率为15.38%(10/65),差异具有统计学意义(χ2=9.108, P=0.003)。CINⅡ~Ⅲ组中ER与Bcl-2蛋白表达存在相关(r=0.506,P〈0.01),其余组中无相关关系。结论:在宫颈病变的进展中, ER和Bcl-2表达呈相反趋势,在CINⅡ~Ⅲ组中有相关性,联合表达阳性可能是宫颈高度上皮内瘤变发生的主要机制之一。 Objective:This study aimed to investigate the relationship between estrogen receptor (ER) and Bcl-2 in cervical can-cer and precancerous lesions. Methods:ER and Bcl-2 were evaluated by immunohistochemistry in 20 non-tumor tissues, 30 low-grade cervical intraepithelial neoplasias, 70 high-grade cervical intraepithelial neoplasias, and 80 cervical cancers. Results:The positive rate of ER was 75%in non-tumor tissues;this rate decreased with disease severity (χ2=24.266, P〈0.01). The overexpression of ER protein was remarkably lower in cervical intraepithelial neoplasias (CIN) Ⅱ-Ⅲ and carcinomas than in non-tumorous cervices. Differences were not significant between CINⅠand non-tumorous cervices (χ2=0.751, P=0.386). Furthermore, ER expression was not correlated with histological type and tumor grade. The positive rate of Bcl-2 was 75.38%in squamous cell carcinoma. This rate increased with dis-ease severity (χ2=27.715, P〈0.01). The Bcl-2 protein overexpression was remarkably higher in CINⅠ, CINⅡ-Ⅲ, and carcinomas than in non-tumorous cervices. Bcl-2 expression was also not correlated with histological type (P=0.500);by comparison, Bcl-2 expression was correlated with tumor pathological grade (χ2=4.862, P=0.027). The co-expression of ER and Bcl-2 was 38.57%and 15.38%in CINⅡ-Ⅲand squamous cell carcinoma, respectively;the differences between these two values were significant (χ2=9.108, P=0.003). A cor-relation between ER and Bcl-2 was observed in CINⅡ-Ⅲ(r=0.506, P〈0.01);no correlation was observed between other groups. Con-clusion: ER expression was inversely correlated with Bcl-2 in cervical cancer progression. The co-expression of these markers may have an important function in the course of high-grade cervical intraepithelial neoplasia.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第23期1427-1430,共4页 Chinese Journal of Clinical Oncology
基金 新疆自治区自然科学基金面上项目(编号:2011211A070)资助~~
关键词 宫颈癌 宫颈上皮内瘤变 雌激素受体 BCL-2蛋白 cervical cancer cervical intraepithelial neoplasm estrogen receptor Bcl-2 protein
  • 相关文献

参考文献15

  • 1Gariglio P, Guti6rrezJ, Cort6s E, et al. The role of retinoid deficien- cy and estrogens as cofactors in cervical cancer[J]. Arch Med Res, 2009, 40(6):449-465.
  • 2Chung SH, Franceschi S, Lambert PF. Estrogen and ERalpha: cul- prits in cervical cancer[J]? Trends Endocrinol Metab, 2010, 21(8): 504-511.
  • 3Thaler S, Schmidt M, Schad A, et al. RASSF1A inhibits estrogen re- ceptor alpha expression and estrogen-independent signalling: impli- cations for breast cancer development[J]. Oncogene, 2012, 31(47): 4912-4922.
  • 4Yu X, Zhang X, Dhakal IB, et al. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells[J]. BMC Cancer, 2012, 12(29):1471-2407.
  • 5Kahn JA. HPV vaccination for the prevention of cervical intraepi- thelial neoplasia[J]. N EngJ Med, 2009, 361(3):271-278.
  • 6zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application [J]. Nat Rev Cancer, 2002, 2(5):342-350.
  • 7Alsbeih G, A1-Harbi N, E1-Sebaie M, et al. HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia[J]. Infect Agent Cancer, 2013, 8(1):15.
  • 8Shai A, Pitot HC, Lambert PF. p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers U]. Cancer Res, 2008, 68(8):2622-2631.
  • 9Rinaldi S, Plummer M, Biessy C, et al. Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study[J]. Can cer Epidemiol Biomarkers Prey, 2011, 20(12):2532-2540.
  • 10王金桃,高尔生,丁玲,程玉英,闫建文.内源性雌孕激素及其受体与宫颈癌的关系[J].中华肿瘤杂志,2006,28(7):494-497. 被引量:18

二级参考文献20

  • 1Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 2002, 55 :244-265.
  • 2Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavims infection: the IARC multicentric case-control study. Lancet, 2002,359: 1085-1092.
  • 3Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet, 2002, 359:1093-1101.
  • 4Elson DA, Riley RR, Lacey A, et al. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.Cancer Res, 2000, 60: 1267-1275.
  • 5Beral V, Hermon C, Kay C, et al. Mortality associated with oral contraceptive use : 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.BMJ, 1999, 318: 96-100.
  • 6Shields TS, Falk RT, Herrero R, et al. A case-control study of endogenous hormones and cervical cancer. Br J Cancer, 2004, 90 :146-152.
  • 7连巧娟.林巧稚妇科肿瘤学[M].3版.北京:人民卫生出版社,2000.209
  • 8Furumoto H,Irahara M.Human papilloma virus (HPV) and cervical cancer[J].J Med Invest,2002,49(3 ~4):124~133
  • 9Costa S,Terzano P,Bovicelli A,et al.CD44 isoform 6 (CD44v6)is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma[J].Gynecol Oncol,2001,80(1):67~73
  • 10Baay MF,Quint WG,Koudstaal J,et al.Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PGR in paraffin-embedded cervical carcinomas[J].J Clin Microbiol,1996,34(3):745~747

共引文献18

同被引文献5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部